Inhibition of endogenous MHC class II-restricted antigen presentation by tacrolimus (FK506) via FKBP51

European Journal of Immunology

Volumn 37, Issue 7, 2007, Pages 1730-1738

  Imai, Akihito ^a   Sahara, Hiroeki ^a   Tamura, Yasuaki ^a   Jimbow, Kowichi ^a   Saito, Tamotsu ^a   Ezoe, Kyori ^a   Yotsuyanagi, Takatoshi ^a   Sato, Noriyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antigen presentation; CD4 T cell; FK506; FKBP51; Minor histocompatibility antigen

Indexed keywords

CYCLOSPORIN A; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 51; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE;

ANIMALS; ANTIGEN PRESENTATION; BLOTTING, WESTERN; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLOSPORINE; DENDRITIC CELLS; FLOW CYTOMETRY; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOSUPPRESSIVE AGENTS; MICE; OVALBUMIN; RNA INTERFERENCE; SIROLIMUS; TACROLIMUS; TACROLIMUS BINDING PROTEINS; TRANSFECTION;

EID: 34447574641     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636392     Document Type: Article

References (34)

1. Calne, R. Y., White, D. J., Thiru, S., Evans, D. B., McMaster, P., Dunn, D. C., Craddock, G. N. et al., Cyclosporine A in patients receiving renal allografts from cadaver donors. Lancet 1978. 2: 1323-1327.
2. Starzl, T. E., Todo, S., Fung, J., Demetris, A. J., Venkataramman, R. and Jain, A., FK 506 for liver, kidney, and pancreas transplantation. Lancet 1989. 2: 1000-1004.
3. European FK506 Multicentre Liver Study Group, Randomised trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection. Lancet 1994. 344: 423-428.
4. Borel, J. F., Pharmacology of cyclosporine (Sandimmune). IV. Pharmacological properties in vivo. Pharmacol. Rev. 1990. 41: 259-371.
5. Kino, T., Hatanaka, H., Miyata, S., Inamura, N., Nishiyama, M., Yajima, T., Goto, T. et al., FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J. Antibiot. 1987. 40: 1256-1265.
6. Liu, J., Farmer, J. D. Jr., Lane, W. S,, Friedman, J., Weissman, I. and Schreiber, S. L., Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991. 66: 807-815.
7. Fruman, D. A., Klee, C. B., Bierer, B. E. and Burakoff, S. J., Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporine A. Proc. Natl. Acad. Sci. USA 1992. 89: 3686-3690.
8. O'Keefe, S. J., Tamura, J., Kincaid, R. L., Tocci, M. J. and O'Neill, E. A., FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 1992. 357: 692-694.
9. Clipstone, N. and Crabtree, G., Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 1992. 357: 695-697.
10. Abe, M. and Thomson, A. W., Influence of immunosuppressive drugs on dendritic cells. Transpl. Immunol. 2003, 11: 357-365.
11. Matsue, H., Yang, C., Matsue, K., Edelbaum, D., Mummert, M. and Takashima, A., Contrasting impacts of immunosuppressive agents (Rapamycin, FK506, Cyclosporin A, and Dexamethasone) on bidirectional dendritic cell-T cell interaction during antigen presentation. J. Immunol. 2001. 169: 3555-3564.
12. Lee, Y., Yang, I., Lee, Y., Im, S., Song, S., Li, K., Han, K. et al., Cyclosporin A and tacrolimus, but not repamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells. Blood 2005. 105: 3951-3955.
13. Voogt, P. J., Fibbe, W. E., Marijt, W. A., Goulmy, E., Veenhof, W. F., Hamilton, M., Brand, A. et al., Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet 1990. 335: 131-134.
14. Goulmy, E., Schipper, R., Pool, J., Blokland, E., Falkenburg, J. H., Vossen, J., Gratwohl, A. et al., Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N. Engl. J. Med. 1996. 334: 281-285.
15. Wallny, H. J. and Rammensee, H. G., Identification of classical minor histocompatibility antigen as cell-derived peptide. Nature 1990. 343: 275-278.
16. Mendoza, L., Villaflor, G., Eden, P., Roopenian, D. and Shastri, N., Distinguishing self from nonself. Immunogenicity of the murine H47 locus is determined by a single amino acid substitution in an unusual peptide. J. Immunol. 2001. 166: 4438-4445.
17. Simpson, E., Scott, D. and Chandler, P., The male-specific histocompatibility antigen, H-Y: A history of transplantation, immune response genes, sex determination and expression cloning. Annu. Rev. Immunol. 1997. 15: 39-61.
18. Scott, D., Addey, C., Ellis, P., James, E., Mitchell, M. J., Saut, N., Jurcevic, S. et al., Dendritic cells permit identification of genes encoding MHC class II-restricted epitopes of transplantation antigens. Immunity 2000. 12: 711-720.
19. Sahara, H. and Shastri, N., Second class minor: Molecular identification of the autosomal H46 histocompatibility locus as a peptide presented by major histocompatibility complex class II molecules. J. Exp. Med. 2003. 197: 375-385.
20. Sanderson, S., Frauwirth, K. and Shastri, N., Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins. Proc. Natl. Acad. Sci. USA 1995. 92: 7217-7221.
21. Siekierka, J. J., Hung, S. H. Y., Poe, M., Lin, C. S. and Sigal, N. H., A cytosolic binding protein for the immunosuppressant FK-506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 1989. 341: 755-757.
22. Harding, M. W., Galat, A., Uehling, D. E. and Schreiber, S. L., A receptor for the immunosuppressant FK-506 is a cis-trans peptidyl-prolyl isomerase. Nature 1989. 341: 758-760.
23. Takahashi, N., Hayano, R. and Suzuki, M., Pepticlyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 1989. 337: 473-475.
24. Fisher, G., Wittmann-Liebed, B., Lang, K., Kieffhaber, T. and Schmid, F., Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 1989. 337: 476-478.
25. Bierer, B. E., Somers, P. K., Wandless, T. J., Burakoff, S. L. and Schreiber, S. L., Probing immunosuppressant action with a nonnatural immunophilin ligand. Science 1990. 250: 556-559.
26. Sigal, N. H., Dumont, F., Durette, P., Sickieka, J. J., Peterson, L., Rich, D. H., Dunlap, B. E. et al., Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A? J. Exp. Med. 1991. 173: 619-628.
27. Liu, J., Farmer, J. D. Jr., Lane, W. S., Friedman, J., Weissman, I. and Schreiber, S. L., Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991. 66: 807-815.
28. +, calcineurin, and NF-AT. Cell 1999. 96: 611-614.
29. Sinars, C. R., Cheung-Flynn, J., Rimerman, R. A., Scammell, J. G., Smith, D. F. and Clardy, J., Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complex. Proc. Natl. Acad. Sci. USA 2003. 100: 868-873.
30. Pratt, W. B. and Toft, D. O., Steroid receptor interactions with heat Shock protein and immunophilin chaperones. Endocr. Rev. 1997. 18: 306-360.
31. Riggs, D. L., Roberts, P. J., Chirillo, S. C., Cheung-Flynn, J., Prapapanich, V., Ratajczak, T., Gaber, R. et al., The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo. EMBO J. 2003. 22: 1158-1167.
32. Wochnik, G. M., Rüegg, J., Abel, G. A., Schmidt, U., Holsboer, F. and Rein, T., FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J. Biol. Chem. 2005. 280: 4906-4616.
33. Trombetta, E. S. and Mellman, I., Cell biology of antigen processing in vitro and in vivo. Annu. Rev. Immunol. 2005. 23: 975-1028.
34. Nakanishi, K., Kamiguchi, K., Torigoe, T., Nabeta, C., Hirohashi, Y., Asanuma, H., Tobioka, H. et al., Localization and function in endoplasmic reticulum stress tolerance of ERdj3, a new member of Hsp40 family protein. Cell Stress Chaperones 2004. 9: 253-264.